Toolkit
Latest project information
EME - 13/50/12
Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
Project title: Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
Call to action: 13/50 13/50 Skin Disorders
Research type: Primary Research
Chief investigator: Professor Carsten Flohr
Contractor: King's College London
Cost: £918,483.17
Co-investigators: Dr Ashley Jones, Dr Emma Wedgeworth, Dr Fiona Browne, Dr Nicola Harman, Dr Paula Beattie, Miss Mandy Wan
, Professor Alan Irvine, Professor Leonie Taams
, Professor Luke O'Neill, Professor Nicholas Webb
, Professor Paula Williamson
.
Started: May 2015 | Status: Research in progress
ISRCTN: 15837754
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research